1887

Chapter 14 : Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818326/9781555810924_Chap14-1.gif /docserver/preview/fulltext/10.1128/9781555818326/9781555810924_Chap14-2.gif

Abstract:

This chapter presents epidemiologic data on the incidence of myocarditis and dilated cardiomyopathy (DCM) and their associations with enteroviruses. The pathogenesis of enterovirus-induced heart disease is comprehensively reviewed, with particular attention given to experimental studies elucidating the viral and immunologic mechanisms of the disease process. The chapter gives an overview of pathology, and talks about viral replication in the heart, host defense mechanisms, cell-mediated destruction of myofibers, virus participation in chronic heart disease, autoimmunity, viral infection and cardiac dysfunction, and factors affecting disease severity. Next, it reviews the detection of enteroviral infection in patients with myocarditis and DCM. It also describes the clinical features of myocarditis and DCM, and discusses evidence that these diseases are two ends of the same disease spectrum. Finally, the chapter reviews conventional treatments for patients with myocarditis and DCM. In addition, the role of immunosuppression and future avenues of therapy are also examined.

Citation: Martino T, Liu P, Sole M, Petric M. 1995. Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies, p 291-351. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch14

Key Concept Ranking

Coronary Artery Disease
0.49323854
Theiler's Murine Encephalomyelitis
0.4204164
Herpes simplex virus 1
0.412244
0.49323854
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Transverse cross-sectional slice of representative heart from virus-infected mice. Note the multifocal nature of the myocardial lesions, which consist of necrotic myocardial cells and an inflammatory cell infiltrate. Hematoxylin and eosin stain. Magnification, Xl5. Reproduced from the Journal of Clinical Investigation ( ), by copyright permission of the American Society for Clinical Investigation.

Citation: Martino T, Liu P, Sole M, Petric M. 1995. Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies, p 291-351. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Light microscopic sections of representative murine hearts. (A) Pathologic changes in CVB3 murine myocarditis. Note the massive myocardial necrosis and inflammatory cell infiltrate in the ventricular myocardium of an A/J mouse at day 7 postinfection. (B) Control heart from an uninfected age-matched mouse. Hematoxylin and eosin stain. Magnification, X40.

Citation: Martino T, Liu P, Sole M, Petric M. 1995. Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies, p 291-351. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Microvascular perfusion from thick sections. Microfil (liquid silicone rubber) was perfused to cast the coronary vessels. (A) Control (verapamil treated) on day 14, with many smooth vessels. (B) Virus-infected heart on day 14. Vessels show multiple focal areas of constriction and narrowing. Magnification, Xl00. The photograph was kindly contributed to our laboratory by Fayez Dawood and Wen-Hu Wen.

Citation: Martino T, Liu P, Sole M, Petric M. 1995. Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies, p 291-351. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

Proposed mechanisms involved in the pathogenesis of DCM following viral myocarditis. Reprinted with permission from the American College of Cardiology ( ).

Citation: Martino T, Liu P, Sole M, Petric M. 1995. Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies, p 291-351. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818326.chap14
1. Abelmann, W. H. 1971. Virus and the heart. Circulation 44: 950 956.
2. Abelmann, W. H. 1984. Classification and natural history of primary myocardial disease. Prog. Cardiovasc. Dis. 27: 73 94.
3. Abelmann, W. H. 1985. Incidence of dilated cardiomyopathy. Postgrad. Med. J. 61: 1123 1124.
4. Abelmann, W. H., 1988. Etiology, pathogenesis, and pathophysiology of dilated cardiomyopathy, p. 3 22. Jit H.-P. Schultheiss (ed.), New Concepts in Viral Heart Disease. Springer-Verlag, Berlin.
5. Abzug, M. J.,, H. A. Rotbart,, and M. J. Levin. 1989. Demonstration of a barrier to transplacental passage of murine enteroviruses in late gestation. J. Infect. Dis. 159: 761 765.
6. Abzug, M. J.,, H. A. Rotbart,, S. A. Magliato,, and M. J. Levin. 1991. Evolution of the placental barrier to fetal infection by murine enteroviruses. J. Infect. Dis. 163: 1336 1341.
7. Ahmed, R.,, L. D. Butler,, and L. Bhatti. 1988. T4 + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62: 2102 2106.
8. Akinkugbe, O. O.,, G. D. Nicholson,, and J. K. Cruickshank. 1991. Heart disease in blacks of Africa and the Caribbean. Cardiovasc. Clin. 2( 3): 377 391.
9. Anderson, J. L.,, J. F. Carlquist,, and E. H. Hammond. 1982. Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy. Lancet ii: 1124 1127.
10. Anderson, J. L.,, J. F. Carlquist,, J. R. Lutz,, C. W. DeWitt,, and E. H. Hammond. 1984. HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am. J. Cardiol. 53: 1326 1330.
11. Arai, K.,, F. Lee,, A. Miyajima,, S. Miyatake,, N. Arai,, and T. Yokota. 1990. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59: 783 836.
12. Archard, L. C.,, N. E. Bowles,, L. Cunningham,, C. A. Freeke,, E. G. J. Olsen,, M. L. Rose,, B. Meany,, H. J. F. Why,, and P. J. Richardson. 1991. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur. Heart J. Suppl. D 12: 56 59.
13. Archard, L. C.,, N. E. Bowles,, E. G. J. Olsen,, and P. J. Richardson. 1987. Detection of persistent coxsackie B virus RNA in dilated cardiomyopathy and myocarditis. Eur. Heart J. Suppl. J 8: 437 440.
14. Aretz, H. T. 1987. Myocarditis: the Dallas criteria. Hum. Pathol. 18: 619 624.
15. Aretz, H. T.,, M. E. Billingham,, W. D. Edwards,, S. M. Factor,, J. T. Fallon,, J. J. Fenoglio Jr.,, E. G. J. Olsen,, and F. J. Schoen. 1987. Myocarditis. A histopathologic definition and classification. Am. J. Cardiovasc. Pathol. 1: 3 14.
16. Argo, E.,, B. Gimenez,, and P. Cash. 1992. Non-cytopathic infection of rhabdomyosarcoma cells by coxsackie B5 virus. Arch. Virol. 126: 215 229.
17. Bagger, J. P.,, U. Baandrup,, K. Rasmussen,, M. Moeller,, and T. Vesterlund. 1984. Cardiomyopathy in western Denmark. Br. Heart J. 52: 327 331.
18. Baker, D. A.,, and C. A. Phillips. 1980. Maternal and neonatal infection with coxsackievirus. Obstet. Gynecol. 55( Suppl.): 12S 15S.
18a. Ballingand, J.-L.,, R. A. Kelly,, P. A. Marsden,, T. W. Smith,, and T. Michel. 1993. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA 90: 347 351.
18b. Balligand, J.-L.,, D. Ungureanu,, R. A. Kelly,, L. Kobzik,, D. Pimental,, T. Michel,, and T. W. Smith. 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91: 2314 2319.
18c. Balligand, J.-L.,, D. Ungureanu,, D. Pimental,, R. A. Kelly,, T. W. Smith,, and T. Michel. 1993. Detection of transcripts for a cytokine inducible nitric oxide synthase isoform in adult rat ventricular myocytes. Circulation 88: 1 384.
19. Bandt, C. M.,, N. A. Staley,, and G. R. Noren. 1979. Acute viral myocarditis: clinical and histologic changes. Minn. Med. 62: 234 237.
20. Beck, M. A.,, N. M. Chapman,, B. M. McManus,, J. C. Mullican,, and S. Tracy. 1990. Secondary enterovirus infection in the murine model of myocarditis. Am. J. Pathol. 136: 669 681.
21. Beck, M. A.,, P. C. Kolbeck,, L. H. Rohr,, Q. Shi,, V. C. Morris,, and O. A. Levander. 1994. Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice. J. Nutr. 124: 345 358.
22. Beck, M. A.,, and S. M. Tracy. 1989. Murine cell-mediated immune response recognizes an enterovirus group-specific antigen(s). J. Virol. 63: 4148 4156.
23. Beisel, K.W.,, J. Srinivasappa,, M. R. Olsen,, A. C. Stiff,, K. Essani,, and B. S. Prabhakar. 1990. A neutralizing monoclonal antibody against coxsackievirus B4 cross-reacts with contractile muscle proteins. Microb. Pathog. 8: 151 156.
24. Beisel, K. W.,, J. Srinivasappa,, and B. S. Prabhakar. 1991. Identification of a putative shared epitope between coxsackie virus B4 and alpha cardiac myosin heavy chain. Clin. Exp. Immunol. 86: 49 55.
25. Beisel, K. W.,, J. Srinivasappa,, and B. S. Prabhakar. 1991. Molecular cloning of a heart antigen that cross-reacts with a neutralizing antibody to coxsackievirus B4. Eur. Heart J. Suppl. D 12: 60 64.
26. Bendinelli, M.,, D. Matteucci,, P. G. Conaldi,, A. M. Giangregorio,, M. R. Capobianchi,, and F. Dianzani. 1987. Mechanisms of group B coxsackie virus persistence in human cells. Eur. Heart J. Suppl. J 8: 441 444.
27. Bengtsson, E.,, and B. Lamberger. 1966. Five-year follow-up study of cases suggestive of acute myocarditis. Am. Heart J. 72: 751 763.
28. Bergelson, J. M.,, M. P. Shepley,, B. M. C. Chan,, M. E. Hemler,, and R. W. Finberg. 1992. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255: 1718 1720.
29. Bergstrom, K.,, U. Erikson,, F. Nordbring,, B. Nordgren,, and A. Parrow. 1970. Acute non-rheumatic myopericarditis: a follow-up study. Scand. J. Infect. Dis. 2: 7 16.
30. Billingham, M. E. 1989. Myocarditis and endomyocardial biopsy. Ann. Intern. Med. 110: 165 166.
31. Blacklow, N. R.,, F. B. Rose,, and R. A. Whalen. 1975. Organ culture of human aorta: prolonged survival with support of viral replication. J. Infect. Dis. 131: 575 578.
32. Blay, R.,, K. Simpson,, K. Leslie,, and S. A. Huber. 1989. Coxsackievirus-induced disease. CD4 + cell initiate both myocarditis and pancreatitis in DBA/2 mice. Am. f. Pathol. 135: 899 907.
33. Boring, W. D.,, G. M. ZuRhein,, and D. L. Walker. 1956. Factors influencing host-virus interactions. II. Alteration of coxsackie virus infection in adult mice by cold. Proc. Soc. Exp. Biol. Med. 93: 273 277.
34. Bowles, N. E.,, P. J. Richardson,, E. G. J. Olsen,, and L. C. Archard. 1986. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet i: 1120 1123.
35. Bowles, N. E.,, M. L. Rose,, P. Taylor,, N. R. Banner,, P. Morgan-Capner,, L. Cunningham,, L. C. Archard,, and M. H. Yacoub. 1989. End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 80: 1128 1136.
36. Burch, G. E.,, S. C. Sun,, H. L. Colcolough,, R. S. Sohal,, and N. P. DePasquale. 1967. Coxsackie B viral myocarditis and valvulitis identified in routine autopsy specimens by immunoflourescent techniques. Am. Heart J. 74: 13 23.
37. Byrne, J. A.,, and M. B. A. Oldstone. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51: 682 686.
38. Cafario, A. L. P.,, E. Bonifacio,, J. T. Stewart,, D. Neglia,, O. Parodi,, G. F. Bottazzo,, and W. J. McKenna. 1990. Novel organ-specific circulating autoantibodies in dilated cardiomyopathy. J. Am. Coll. Cardiol. 15: 1527 1534.
39. Cambridge, C.,, C. G. C. MacArthur,, A. P. Waterson,, J. F. Goodwin,, and C. M. Oakley. 1979. Antibodies to coxsackie B viruses in congestive cardiomyopathy. Br. Heart J. 41: 692 696.
40. Carlquist, J. R.,, R. L. Menlove,, M. B. Murray,, J. B. O'Connell,, and J. L. Anderson. 1991. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and metaanalysis of published HLA association studies. Circulation 83: 515 522.
41. Carrio, I.,, L. Berna,, M. Ballester,, M. Estorch,, D. Obrador,, M. Cladellas,, L. Abadal,, and M. Ginjaume. 1988. Indium-Ill antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J. Nucl. Med. 29: 1893 1900.
42. Casans, I.,, A. Villar,, V. Almenar,, and A. Blanes. 1989. Lyme myocarditis diagnosed by indium-Ill antimyosin scintigraphy. Eur.J. Nucl. Med. 15: 330 331.
43. Chandraranta, R. A.,, W. G. Bradley,, K. E. Korman,, S. Minagoe,, M. Delvicario,, and S. H. Rahimtoola. 1987. Detection of acute myocarditis using nuclear magnetic resonance imaging. Am. J. Med. 83: 1144 1146.
44. Cheever, F. S. 1953. Multiplication of coxsackie virus in adult mice exposed to Roentgen radiation. J. Immunol. 71: 431 435.
45. Cherry, J. D., 1990. Enteroviruses, p. 325 366. In J. S. Remington, and J. O. Klein (ed.), Infectious Diseases of the Fetus and Newborn Infant. The W. B. Saunders Co., Philadelphia.
46. Cho, C. T.,, K. K. Feng,, V. R McCarthy,, and M. F. Lenahan. 1982. Role of antiviral antibodies in resistance against coxsackievirus B3 infection: interaction between preexisiting antibodies and an interferon inducer. Infect. Immun. 37: 720 727.
47. Chow, L. H.,, K. W. Beisel,, and B. M. McManus. 1992. Enteroviral infection of mice with severe combined immunodeficiency: evidence for direct viral pathogenesis of myocardial injury. Lab. Invest. 66: 24 31.
48. Chow, L. H.,, C. J. Gauntt,, and B. M. McManus. 1991. Differential effects of myocarditic variants of coxsackievirus B3 in inbred mice. A pathological characterization of heart tissue damage. Lab. Invest. 64: 55 64.
49. Chow, L. H.,, S. J. Radio,, T. D. Sears,, and B. M. McManus. 1989. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J. Am. Coll. Cardiol. 14: 915 920.
50. Codd, M. B.,, D. D. Sugrue,, B. J. Gersh,, and L. J. Melton. 1989. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. Circulation 80: 564 572.
51. Correa, P.,, C. Restrepo,, C. Garcia,, and A. C. Quiroz. 1963. Pathology of heart disease of undetermined etiology which occur in Cali, Colombia. Am. Heart J. 66: 584 596.
52. Costanzo-Nordin, M. R.,, E. A. Reap,, J. B. O'Connell,, J. A. Robinson,, and P. J. Scanlon. 1985. A nonsteroid anti-inflammatory drug exacerbates coxsackie B3 murine myocarditis. J. Am. Coll. Cardiol. 6: 1078 1082.
53. Craighead, J. E.,, S. A. Huber,, and S. Sriram. 1990. Biology of disease. Animal models of picornavirus-induced autoimmune disease: their possible relevance to human disease. Lab. Invest. 63: 432 446.
54. Cronin, M. E.,, L. A. Love,, F. W. Miller,, P. R. McClintock,, and P. H. Plotz. 1988. The natural history of encephalomyocarditis virus-induced myositis and myocarditis in mice. Viral persistence demonstrated by in situ hybridization. J. Exp. Med. 168: 1639 1648.
55. Crowell, R. L. 1963. Specific viral interference in HeLa cell cultures chronically infected with coxsackie B5 virus. J. Bacteriol. 86: 517 526.
56. Crowell, R. L.,, A. K. Field,, W. A. Schleif,, W. L. Long,, R. J. Colonno,, J. E. Mapoles,, and E. A. Emini. 1986. Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade. J. Virol. 57: 438 445.
57. Cunningham, M. W.,, S. M. Antone,, J. M. Gulizia,, B. M. McManus,, V. A. Fischetti,, and C. J. Gauntt. 1992. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc. Natl. Acad. Sci. USA 89: 1320 1324.
58. Cunningham, M. W.,, S. M. Antone,, J. M. Gulizia,, B. A. McManus,, and C. J. Gauntt. 1993. (3-Helical coiled-coil molecules: a role in autoimmunity against the heart. Clin. Immunol. Immunopathol. 68: 118 123.
59. DaUdorf, G.,, and R. Gifford. 1954. Susceptibility of gravid mice to coxsackie virus infection.}. Exp. Med. 99: 21 27.
60. Dalldorf, G.,, and J. L. Melnick,. 1965. Coxsackie viruses, p. 474 512. In F. L. Horsfall, Jr.,, and I. Tamm (ed.), Viral and Rickettsial Infections of Man, 4th ed. L. B. Lippincott Co., Philadelphia.
61. De Belder, A. J.,, M. W. Radomski,, H. J. F. Why,, P. J. Richardson,, C. A. Bucknall,, E. Salas,, J. F. Martin,, and S. Moncada. 1993. Nitric oxide synthase activities in human myocardium. Lancet 341: 84 85.
62. Dec, W. G.,, I. Palacios,, T. Yasuda,, J. T. Fallon,, B. A. Khaw,, H. W. Strauss,, and E. Haber. 1990. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J.Am. Coll. Cardiol. 16: 97 104.
63. De Clerco, E.,, J. Murase,, and V. E. Marquez. 1991. Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase. Biochem. Pharmacol. 41: 1821 1829.
64. de la Torre, J. C.,, M. Davila,, F. Sobrino,, J. Ortin,, and E. Domingo. 1985. Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology 145: 24 35.
65. Demakis, J. G.,, and S. H. Rahimtoola. 1971. Peripartum cardiomyopathy. Circulation 44: 964 968.
66. De Maria, R.,, A. Gavazzi,, F. Recalcati,, G. Baroldi,, C. De Vita,, and F. Camerini. 1993. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. Am. J. Cardiol. 72: 580 585.
67. De Ward, M.J. D. 1992. How can myocarditis be diagnosed and should it be treated? Br. Heart J. 68: 346 347 (Editorial).
68. Dianzani, F.,, M. R. Capobianchi,, D. Matteucci,, and M. Bendinelli,. 1988. The role of interferon in picornavirus infections, p. 65 80. In M. Bendinelli and H. Friedman (ed.), Coxsackieviruses: a General Update. Plenum Press, New York.
69. Doherty, P. C.,, W. Allen,, and M. Eichelberger. 1992. Roles of dp" and y8T cell subsets in viral immunity. Annu. Rev. Immunol. 10: 123 151.
70. Dong, R.,, P. Liu,, L. Wee,, J. Butany,, and M.J. Sole. 1992. Verapamil ameliorates the clinical and pathological course of murine myocarditis. J. Clin. Invest. 90: 2022 2030.
71. Drude, L.,, F. Wiemers,, and B. Maisch. 1991. Impaired myocyte function in vitro incubated with sera from patients with myocarditis. Eur. Heart J. Suppl. D 12: 36 38.
72. Easton, A. J.,, and R. P. Eglin. 1988. The detection of coxsackievirus RNA in cardiac tissue by in situ hybridization. J. Gen. Virol. 69: 285 291.
73. Eckstein, R.,, W. Mempel,, and H.-D. Bolte. 1982. Reduced suppressor cell activity in congestive cardiomyopathy and myocarditis. Circulation 65: 1224 1229.
74. El-Hagrassy, M. M. O.,, and J. E. Banatvala. 1980. Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases. Lancet ii: 1160 1162.
75. Ertl, G.,, B. Bauer,, S. Neubauer,, W. Schorb,, and K. Kochsiek. 1991. Effect of mediators on coronary circulation. Eur. Heart J. Suppl. D 12: 187 189.
76. Estrin, M.,, M. Herzum,, C. Buie,, and S. A. Huber. 1987. Immunosuppressives in murine myocarditis. Eur. Heart J. Suppl. J 8: 259 262.
77. Estrin, M.,, and S. A. Huber. 1987. Coxsackievirus B3 induced myocarditis: autoimmunity is L3T4 + T helper cell and IL-2 independent in Balb/c mice. Am. J. Pathol. 127: 335 341.
78. Factor, S. M.,, T. Minase,, S. Cho., R. Dominitz, and E. H. Sonnenblick. 1982. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation 66: 342 354.
79. Factor, S. M.,, H. Tanowitz,, M. Wittner,, and M. C. Ventura. 1993. Interstitial connective tissue matrix alterations in acute murine Chagas' disease. Clin. Immunol. Immunopathol. 68: 147 152.
80. Farrar, M. A.,, and R. D. Schreiber. 1993. The molecular cell biology of interferon-g and its receptor. Annu. Rev. Immunol. 11: 571 611.
81. Federici, E. E.,, A. M. Lerner,, and W. H. Abelmann. 1963. Observations on the course of coxsackie A-9 myocarditis in C3H mice. Proc. Soc. Exp. Biol. Med. 112: 672 676.
82. Felix, J. C.,, B. F. von Kreuter,, and C. A. Santos-Buch. 1993. Mimicry of heart cell surface epitopes in primary anti-trypanosoma cruzi Lyt 2 + T lymphocytes. Clin. Immunol. Immunopathol. 68: 141 146.
83. Finkel, M. S.,, C. V. Oddis,, T. D. Jacob,, S. C. Watkins,, B. G. Hattler,, and R. L. Simmons. 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387 389.
84. Fohlman, J.,, N.-G. Dback,, G. Friman,, and B. Morein. 1990. Vaccination of Balb/c mice against enteroviral mediated myocarditis. Vaccine 8: 381 384.
85. Fohlman, J.,, K. Pauksen,, B. Morein,, U. Bjare,, N.-G. Dback,, and G. Friman. 1993. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Scand. J. Infect. Dis. Suppl. 88: 103 108.
86. Foulis, A. K.,, M. A. Farquharson,, S. O. Cameron,, M. McGill,, H. Schonke,, and R. Kandolf. 1990. A search for the presence of the enteroviral capsid protein VP 1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia 33: 290 298.
87. Fowles, R. E.,, C. P. Bieber,, and E. B. Stinson. 1979. Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation 59: 483 491.
88. Frank, J. A.,, E. V. Shmidt,, R. E. Smith,, and C. M. Wilfert. 1986. Persistent infection of rat insulinoma cells with coxsackie B4 virus. Arch. Virol. 87: 143 150.
89. Friman, G.,, and J. Fohlman. 1993. The epidemiology of viral heart disease. Scand. J. Infect. Dis. Suppl. 88: 7 10.
90. Frizelle, S.,, J. Schwarz,, S. A. Huber,, and K. Leslie. 1992. Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice. Am. J. Pathol. 141: 203 209.
91. Fujii, Y.,, F. Sendo,, T. Kamiyama,, and M. Naiki. 1990. IgG antibodies to asialo GM1 are more sensitive than IgM antibodies to kill in vivo natural killer cells and premature cytotoxic T lymphocytes of mouse spleen. Microbiol. Immunol. 34: 533 542.
92. Fuster, V.,, B. J. Gersh,, E. R. Giuliani,, A. J. Tajik,, R. O. Brandenburg,, and R. L. Frye. 1981. The natural history of idiopathic dilated cardiomyopathy. Am. J. Cardiol. 47: 525 531.
93. Gagliardi, M. G.,, M. Bevilacqua,, R. Di Renzi,, S. Picardo,, R. Passariello,, and C. Marcelletti. 1991. Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am. J. Cardiol. 68: 1089 1091.
94. Gatmaitan, B. G.,, J. L. Chason,, and M. Lerner. 1970. Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise. J. Exp. Med. 131: 1121 1136.
95. Gauntt, C. J.,, H. M. Arizpe,, A. L. Higdon,, M. M. Rozek,, R. Crawley,, and M. W. Cunningham. 1991. Anti-coxsackievirus B3 neutralizing antibodies with pathological potential. Eur. Heart J. Suppl. D 12: 124 129.
96. Gauntt, C. J.,, H. M. Arzipe,, J. T. Kung,, K. K. Ogilvie,, and U. O. Cheriyan. 1985. Antimyocarditic activity of the guanine derivative BIOLF-70 in a coxsackievirus B3 murine model. Antimicrob. Agents Chemother. 27: 184 191.
97. Gauntt, C. J.,, A. L. Higdon,, H. M. Arizpe,, M. R. Tamayo,, R. Crawley,, R. D. Henkel,, M. E. A. Pereira,, S. M. Tracy,, and M. W. Cunningham. 1993. Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis. Clin. Immunol. Immunopathol. 68: 129 134.
98. Gauntt, C. J.,, A. Higdon,, D. Bowers,, E. Maull,, J. Wood,, and R. Crawley. 1993. What lessons can be learned from animal model studies in viral heart disease? Scand. J. Infect. Dis. Suppl. 88: 49 65.
99. Gauntt, C. J.,, W. C. Lutton,, E. K. Godeny,, S. M. Witherspoon,, H. M. Arizpe,, and R. E. Lanford. 1987. Murine coxsackie virus B3 myocarditis. Eur. Heart J. Suppl. J 8: 393 397.
100. Gelfand, H. M. 1961. The occurrence in nature of the coxsackie and ECHO viruses. Prog. Med. Virol. 3: 193 244.
101. Gifford, R.,, and G. Dalldorf. 1951. The morbid anatomy of experimental coxsackie virus infection. Am. J. Pathol. 27: 1047 1056.
102. Gillespie, J. S.,, H. M. A. Cavanagh,, W. M. H. Behan,, L. J. A. Morrison,, F. McGarry,, and P. O. Behan. 1993. Increased transcription of interleukin-6 in the brains of mice with chronic enteroviral infection. J Gen. Virol. 74: 741 743.
103. Gobet, R.,, A. Cerny,, E. Ruedi,, H. Hengartner,, and R. M. Zinkernagel. 1988. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus. Exp. Cell. Biol. 56: 175 180.
104. Godeny, E. K.,, R. S. Cassling,, and C. J. Gauntt. 1987. Studies on the mechanism(s) of resistance to coxsackie virus B3 (CVB3)-in-duced myocarditis at adolescence in mice vaccinated at birth with a temperature-sensitive mutant of CVB3. Eur. Heart J. Suppl. J 8: 403 405.
105. Godeny, E. K.,, and C. J. Gauntt. 1986. Involvement of natural killer cells in coxsackievirus B3 viral-induced myocarditis. J. Immunol. 137: 1695 1702.
106. Godeny, E. K.,, and C. J. Gauntt. 1987. Murine natural killer cells limit coxsackievirus B3 replication. J. Immunol. 139: 913 918.
107. Godeny, E. K.,, and C. J. Gauntt. 1987. Interferon and natural killer cell activity in coxsackie virus B3-induced murine myocarditis. Eur. Heart f. Suppl. J 8: 433 435.
108. Goodwin, J. F. 1987. Myocarditis and perimyocarditis. Histological survey, epidemiology and clinical features. Eur. Heart f. Suppl. J 8: 7 9.
109. Goodwin, J. F. 1992. Cardiomyopathies and specific heart muscle diseases. Definitions, terminology, classifications and new and old approaches. Postgrad. Med. J. Suppl. I 68: S3 S6.
110. Gore, I.,, and O. Saphir. 1947. Myocarditis. A classification of 1402 cases. Am. Heart J. 34: 827 830.
111. Goren, A.,, K. Kaplan,, J. Glaser,, and M. Isacsohn. 1989. Chronic neonatal coxsackie myocarditis. Arch. Dis. Child. 64: 404 406.
112. Goudevenos, J.,, G. Parry,, and R. G. Gold. 1990. Coxsackie B4 viral myocarditis causing ventricular aneurysm. Int. J. Cardiol. 27: 122 124.
113. Grasso, M.,, E. Arbustini,, E. Silini,, M. Diegoli,, E. Percivalle,, G. Ratti,, M. Bramerio,, A. Gavazzi,, M. Vigano,, and G. Milanesi. 1992. Search for coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am. J. Cardiol. 69: 658 664.
114. Gravanis, M. G.,, and N. H. Sternby. 1991. Incidence of myocarditis. Arch. Pathol. Lab. Med. 115: 390 392.
115. Greve, J. M.,, G. Davis,, A. M. Meyer,, C. P. Forte,, S. C. Yost,, C. W. Marlor,, M. E. Kamarck,, and A. McClelland. 1989. The major human rhinovirus receptor is ICAM-1. Cell 56: 839 847.
116. Grist, N. R. 1972. Viruses and myocarditis. Postgrad. Med. J. 48: 750 751.
117. Grist, N. R.,, and E. J. Bell. 1974. A six-year study of coxsackievirus B infections in heart disease. J. Hyg. Camb. 73: 165 172.
118. Grist, N. R.,, E. J. Bell,, and F. Assaad. 1978. Enteroviruses in human disease. Prog. Med. Virol. 24: 114 157.
119. Grodums, E. I.,, and G. Dempster. 1959. The age factor in experimental coxsackie B-3 infection. Can. J. Microbiol. 5: 595 604.
120. Grodums, E. I.,, and G. Dempster. 1959. Myocarditis in experimental coxsackie B-3 infection. Can. J. Microbiol. 5: 605 615.
121. Groenewegen, G.,, W. A. Buurman,, and C. J. van der Linden. 1985. Lymphokine dependence of in vivo expression of MHC class II antigens by endothelium. Nature (London) 316: 361 363.
122. Gudvangen, R. J.,, P. S. Duffey,, R. E. Paque,, and C. J. Gauntt. 1983. Levamisole exacerbates coxsackievirus B3-induced murine myocarditis. Infect. Immun. 41: 1157 1165.
122a. Gulick, T.,, M. K. Chung,, S. J. Pieper,, L. G. Lange,, and G. F. Schreiner. 1989. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc. Natl. Acad. Sci. USA 86: 6753 6757.
123. Gupta, S. C.,, H. Hengartner,, and R. M. Zinkernagel. 1986. Primary antibody responses to a well-defined and unique hapten are not enhanced by preimmunization with carrier: analysis in a viral model. Proc. Natl. Acad. Sci. USA 83: 2604 2608.
124. Guthrie, M.,, P. A. Lodge,, and S. A. Huber. 1984. Cardiac injury in myocarditis induced by coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2+ cytolytic lymphocytes. Cell. Immunol. 88: 558 567.
125. Hammond, R. H.,, R. L. Menlove,, R. L. Yowell,, and J. L. Anderson. 1993. Vascular HLA-DR expression correlates with pathological changes suggestive of ischemia in idiopathic dilated cardiomyopathy. Clin. Immunol. Immunopathol. 68: 197 203.
126. Hauck, A. J.,, D. L. Kearney,, and W. D. Edwards. 1989. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for the role of sampling error. Mayo Clin. Proc. 64: 1235 1245.
127. Heck, C. R.,, S. J. Shumway,, and M. R. Kaye. 1989. The registry of the international society for heart transplantation: sixth official report—1989. J. Heart Transplant. 8: 271 276.
128. Heikkila, J.,, and J. Karjalainen. 1982. Evaluation of mild acute infectious myocarditis. Br. Heart J. 47: 381 391.
129. Heim, A.,, A. Canu,, P. Kirschner,, T. Simon,, G. Mall,, P. H. Hofschneider,, and R. Kandolf. 1992. Synergistic interaction of interferon-p and interferon-y in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts. J. Infect. Dis. 166: 958 965.
130. Helin, M.,, J. Savola,, and K. Lapinleimu. 1968. Cardiac manifestations during a coxsackie B5 epidemic. Br. Med. J. 3: 97 99.
131. Hengstenberg, C.,, G. Hufnagel,, A. Haverich,, E. G. J. Olsen,, and B. Maisch. 1993. De novo expression of MHC class I and class II antigens on endomyocardial biopsies from patients with inflammatory heart disease and rejection following heart transplantation. Eur. Heart J. 14: 758 763.
132. Henke, A.,, C. Hohr,, H. Sprenger,, C. Graebner,, A. Stelzner,, M. Nain,, and D. Gemsa. 1992. Coxsackievirus B3-induced production of tumor necrosis factor-α, IL-lβ, and IL-6 in human monocytes. J. Immunol. 148: 2270 2277.
133. Henke, A.,, M. Nain,, A. Stelzner,, and D. Gemsa. 1991. Induction of cytokine release from human monocytes by coxsackievirus infection. Eur. Heart J. Suppl. D 12: 134 136.
134. Henke, A.,, H.-P. Spengler,, A. Stelzner,, M. Nain,, and D. Gemsa. 1992. Lipopolysaccha-ride suppresses cytokine release from coxsackie virus-infected human monocytes. Res. Immunol. 143: 65 70.
135. Henry, Y.,, M. Lepoivre,, J. C. Drapier,, C. Ducrocq,, J. L. Boucher,, and A. Guissani. 1993. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7: 1124 1134.
136. Herzum, M.,, S. A. Huber,, R. Weller,, R. Grebe,, and B. Maisch. 1991. Treatment of experimental murine coxsackie B3 myocarditis. Eur. Heart J. Suppl D 12: 200 202.
137. Hess, A. D. 1993. Mechanisms of action of cyclosporine: considerations for the treatment of autoimmune diseases. Clin. Immunol. Immunopathol. 68: 220 228.
138. Hibbs, R. G.,, V. J. Ferrans,, W. C. Black,, J.J. Walsh,, and G. E. Burch. 1965. Viruslike particles in the heart of a patient with cardiomyopathy. Am. Heart J. 69: 327 337.
139. Hilton, D. A.,, S. Variend,, and J. H. Pringle. 1993. Demonstration of coxsackie virus RNA in formalin-fixed tissue sections from childhood myocarditis cases by in situ hybridization and the polymerase chain reaction. J. Pathol. 170: 45 51.
140. Hofschneider, P. H.,, K. Klingel,, and R. Kandolf. 1990. Toward understanding the pathogenesis of enterovirus-induced cardiomyopathy: molecular and ultrastructural approaches. J. Struct. Biol. 104: 32 37.
141. Hogle, J. M.,, M. Chow,, and D. J. Filman 1985. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 229: 1358 1365.
142. Hohenadl, C.,, K. Klingel,, J. Mertsching,, P. H. Hofschneider,, and R. Kandolf. 1991. Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization. Mol. Cell. Probes 5: 11 20.
143. Holland, J. J. 1961. Receptor affinities as major determinants of enterovirus tissue tropisms in humans. Virology 15: 312 326.
144. Homans, D. C. 1985. Current concepts. Peripartum cardiomyopathy. N. Engl. J. Med. 312: 1432 1437.
145. Hosenpud, J. D.,, S. M. Campbell,, and D. J. Mendelson. 1989. Interleukin-1 induced myocardial depression in an isolated beating heart preparation. J. Heart Transplant. 8: 460 464.
146. Hosenpud, J. D.,, S. M. Campbell,, and G. Pan. 1990. Indirect inhibition of myocyte RNA and protein synthesis by interleukin-1. J. Mol. Cell. Cardiol. 22: 213 225.
147. Hosier, D. M.,, and W. A. Newton. 1958. Serious coxsackie infection in infants and children. Am. J. Dis. Child. 96: 251 267.
148. Hsu, K. H. L.,, and R. L. Crowell. 1989. Characterization of aYAC-1 mouse cell receptor for group B coxsackieviruses. J. Virol. 63: 3105 3108.
149. Hsu, K. H. L.,, K. Lonberg-Holm,, B. Alstein,, and R. L. Crowell. 1988. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J. Virol. 62: 1647 1652.
150. Hsu, K. H. L.,, S. Paglini,, B. Alstein,, and R. L. Crowell,. 1990. Identification of a second cellular receptor for a coxsackievirus B3 variant, CB3-RD, p. 271 277. In M. A. Brinton, and F. X. Heinz (ed.), New Aspects of Positive-Strand RNA Viruses. American Society for Microbiology, Washington D.C.
151. Huber, S. A. 1992. Heat-shock protein induction in adriamycin and picornavirus-infected cardiocytes. Lab. Invest. 67: 218 224.
152. Huber, S. A.,, C. Haisch,, and P. A. Lodge. 1990. Functional diversity in vascular endothelial cells: role in coxsackievirus tropism. J. Virol. 64: 4516 4522.
153. Huber, S. A.,, N. Heintz,, and R. Tracy. 1988. Coxsackievirus B-3 induced myocarditis. Virus and actinomycin D treatment of myocytes induces novel antigens recognized by cytolyticT lymphocytes. J. Immunol. 141: 3214 3219.
154. Huber, S. A.,, and L. P. Job. 1983. Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3. Infect. Immun. 39: 1419 1427.
155. Huber, S. A.,, L. P. Job,, and K. R. Auld. 1982. Influence of sex hormones on coxsackie B-3 virus infection in Balb/c mice. Cell. Immunol. 67: 173 189.
156. Huber, S. A.,, L. P. Job,, K. R. Auld,, and J. F. Woodruff. 1981. Sex-related differences in the rapid production of cytotoxic spleen cells active against uninfected myofibers during coxsackievirus B-3 infection. J. Immunol. 126: 1336 1340.
157. Huber, S. A.,, L. P. Job,, and J. F. Woodruff. 1980. Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes. Am. J. Pathol. 98: 681 694.
158. Huber, S. A.,, L. P. Job,, and J. F. Woodruff. 1981. Sex-related differences in the pattern of coxsackievirus B-3-induced immune spleen cell cytotoxicity against virus-infected myofibers. Infect. Immun. 32: 68 73.
159. Huber, S. A.,, L. P. Job,, and J. F. Woodruff. 1984. In vitro culture of coxsackievirus group B, type 3 immune spleen cells on infected endothelial cells and biological activity of cultured cells in vivo. Infect. Immun. 43: 567 573.
160. Huber, S. A.,, and P. A. Lodge. 1984. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. Am. J. Pathol. 116: 21 29.
161. Huber, S. A.,, and P. A. Lodge. 1986. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/ 2 and Balb/c mice. Am. J. Pathol. 122: 284 291.
162. Huber, S. A.,, J. Polgar,, P. Schultheiss,, and P. Schwimmbeck. 1994. Augmentation of pathogenesis of coxsackievirus B3 infection in mice by exogenous administration of IL-1 and IL-2. J. Virol. 68: 195 206.
163. Hufnagel, G.,, and B. Maisch. 1991. Expression of MHC class I and II antigens and the 11-2 receptor in rejection, myocarditis and dilated cardiomyopathy. Eur. Heart. J. Suppl. D 12: 137 140.
164. Hyypia, T.,, M. Kallajoki,, M. Maaronen,, G. Stanway,, R. Kandolf,, P. Auvinen,, and H. Kalimo. 1993. Pathogenetic differences between coxsackie A and B virus infections in newborn mice. Virus Res. 27: 71 78.
165. Ilback, N.-G.,, J. Fohlman,, and G. Friman. 1989. Exercise in coxsackie B3 myocarditis: effects on heart lymphocyte sub-populations and the inflammatory reaction. Am. Heart J. 117: 1298 1302.
166. Ilback, N.-G.,, J. Fohlman,, and G. Friman. 1993. Altered distribution of heavy metals and lipids in coxsackievirus B3 infected mice. Scand.J. Infect. Dis. Suppl. 88: 93 98.
167. Ilback, N.-G.,, J. Fohlman,, S. Slorach,, and G. Friman. 1989. Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine coxsackievirus B3 myocarditis. J. Immunol. 142: 3225 3228.
168. Ilback, N.-G.,, A. Mohammed,, J. Fohlman,, and G. Friman. 1990. Cardiovascular lipid accumulation with coxsackie B virus infection in mice. Am. J. Pathol. 136: 159 167.
169. Ilback, N.-G.,, L. Wesslen,, K. Pauksen,, T. Stalhandske,, G. Friman,, and J. Fohlman. 1993. Effects of the antiviral WIN 54954 and the immune modulator LS 2616 on cachectin/ TNF and y-interferon responses during viral heart disease. Scand. J. Infect. Dis. Suppl. 88: 117 123.
170. Jin, O.,, M. J. Sole,, J. W. Butany,, W.-K. Chia,, P. R. McLaughlin,, P. Liu,, and C.-C. Liew. 1990. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 82: 8 16.
171. Job, L. P.,, D. C. Lyden,, and S. A. Huber. 1986. Demonstration of suppressor cells in coxsackievirus group B, type 3 infected female Balb/c mice which prevent myocarditis. Cell. Immunol. 98: 104 113.
172. Jubelt, B.,, A. K. Wilson,, S. L. Ropka,, P. L. Guidinger,, and M. A. McKinlay. 1989. Clearance of a persistent human enterovirus infection of the mouse central nervous system by the antiviral agent disoxaril. J. Infect. Dis. 159: 866 871.
173. Julian, D. G.,, and P. Szekely. 1985. Peripartum cardiomyopathy. Prog. Cardiovasc. Dis. 27: 223 240.
174. Kamijo, R.,, H. Harada,, T. Matsuyama,, M. Bosland,, J. Gerecitano,, D. Shapiro,, J. Le,, S. I. Koh,, T. Kimura,, S. J. Green,, T. W. Mak,, T. Taniguchi,, and J. Vilcek. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263: 1612 1615.
175. Kandolf, R., 1988. The impact of recombinant DNA technology on the study of enterovirus heart disease, p. 293 318. In M. Bendinelli, and H. Friedman (ed.), Coxsackieviruses: a General Update. Plenum Press, New York.
176. Kandolf, R.,, D. Ameis,, P. Kirschner,, A. Canu,, and P. H. Hofschneider. 1987. In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc. Natl. Acad. Sci. USA 84: 6272 6276.
177. Kandolf, R.,, A. Canu,, and P. H. Hofschneider. 1985. Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J. Mol. Cell. Cardiol. 17: 167 181.
178. Kandolf, R.,, A. Canu,, K. Klingel,, P. Kirschner,, H. Schdnke,, J. Mertsching,, R. Zell,, and P. H. Hofschneider,. 1990. Molecular studies on enteroviral heart disease, p. 340 348. In M. A. Brinton, and F. X. Heinz (ed.), New Aspects of Positive-Strand RNA Viruses. American Society for Microbiology, Washington D.C.
179. Kandolf, R.,, and P. H. Hofschneider. 1989. Enteroviral heart disease. Springer Semin. Immunopathol. 11: 1 13.
180. Kandolf, R.,, P. Kirschner,, D. Ameis,, A. Canu,, and P. H. Hofschneider. 1987. Cultured human heart cells: a model system for the study of the antiviral activity of interferons. Eur. Heart J. Suppl. J 8: 453 456.
181. Kandolf, R.,, K. Klingel,, H. Mertsching,, A. Canu,, C. Hohenadl,, R. Zell,, B. Y. Reimann,, A. Heim,, B. M. McManus,, A. K. Foulis,, H. P. Schultheiss,, E. Erdmann,, and G. Riecker. 1991. Molecular studies on enteroviral heart disease: patterns of acute and persistent infections. Eur. Heart J. Suppl. D 12: 49 55.
182. Kandolf, R.,, K. Klingel,, R. Zell,, A. Canu,, U. Fortmuller,, C. Hohenadl,, M. Albrecht,, B.-Y. Reimann,, W. M. Franz,, A. Heim,, U. Raab,, and F. McPhee. 1993. Molecular mechanisms in the pathogenesis of enteroviral heart disease: acute and persistent infections. Clin. Immunol. Immunopathol. 68: 153 158.
183. Kaplan, M. H.,, S. W. Klein,, J. McPhee,, and R. G. Harper. 1983. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev. Infect. Dis. 5: 1019 1032.
184. Karjalainen, J. 1993. Clinical diagnosis of myocarditis and dilated cardiomyopathy. Scand. J. Infect. Dis. Suppl. 88: 33 43.
185. Karjalainen, J.,, and J. Heikkila. 1986. "Acute pericarditis": myocardial enzyme release as evidence for myocarditis. Am. Heart J. 111: 546 552.
186. Karjalainen, J.,, J. Heikkila,, M. S. Nieminen,, H. Jalanko,, M. Kleemola,, K. Lapinleimu,, and T. Sahi. 1983. Etiology of mild acute infectious myocarditis. Relation to clinical features. Acta Med. Scand. 213: 65 73.
187. Karupiah, G.,, Q.-W. Xie,, R. M. L. Buller,, C. Nathan,, C. Duarte,, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-y-induced nitric oxide synthase. Science 261: 1445 1448.
188. Kasai, M.,, D. M. Iwamori,, Y. Nagai,, K. Okumura,, and T. Tada. 1980. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol. 10: 175 180.
189. Kawai, C. 1971. Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease. Jpn. Circ.J. 35: 765 770.
190. Kawai, C.,, A. Matsumori,, Y. Kitaura,, and T. Takatsu. 1978. Viruses and the heart: viral myocarditis and cardiomyopathy. Prog. Cardiol. 7: 141 162.
191. Kawai, C.,, and T. Takatsu. 1975. Clinical and experimental studies on cardiomyopathy. N. Engl. J. Med. 293: 592 597.
192. Keeling, P. J.,, S. Jeffery,, A. Caforio,, R. Taylor,, G. F. Bottazzo,, M. J. Davies,, and W. J. McKenna. 1992. Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction. Br. Heart J. 68: 554 559.
193. Keren, A.,, and R. L. Popp. 1992. Assignment of patients into the classification of cardiomyopathies. Circulation 86: 1622 1633.
194. Kilbourne, E. D.,, and F. L. Horsfall, Jr. 1951. Lethal infection with coxsackie virus of adult mice given cortisone. Proc. Soc. Exp. Biol. Med. 77: 135 138.
195. Kilbourne, E. D.,, C. B. Wilson,, and D. Perrier. 1956. The induction of gross myocardial lesions by a coxsackie (pleurodynia) virus and cortisone. J. Clin. Invest. 35: 362 370.
196. Kishimoto, C.,, K. A. Thorp,, and W. H. Abelmann. 1990. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine coxsackievirus B3 myocarditis. Circulation 82: 982 989.
197. Kitaura, Y. 1981. Virological study of idiopathic cardiomyopathy; serological study of virus antibodies and immunofluorescent study of myocardial biopsies. Jpn. Circ.J. 45: 279 294.
198. Klein, J. O.,, and J. S. Remington,. 1990. Current concepts on infections of the fetus and newborn infant, p. 1 16. In J. S. Remington, and J. O. Klein (ed.), Infectious Diseases of the Fetus and Newborn Infant. The W. B. Saunders Co., Philadelphia.
199. Klingel, K.,, C. Hohenadl,, A. Canu,, M. Albrecht,, M. Seemann,, G. Mall,, and R. Kandolf. 1992. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. USA 89: 314 318.
200. Klingel, K.,, and R. Kandolf. 1993 The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains. Scand. J. Infect. Dis. Suppl. 88: 79 85.
201. Klump, W. M.,, I. Bergmann,, B. C. Miiller,, D. Ameis,, and R. Kandolf. 1990. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis. J. Virol. 64: 1573 1583.
202.Koberle, E 1957. Die chronische Chagaskardiopathie. Virchows Arch. 330: 267295.
203. Koide, H.,, Y. Kitaura,, H. Deguchi,, A. Ukimura,, K. Kawamura,, and K. Hirai. 1992. Genomic detection of enteroviruses in the myocardium. Studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy. Jpn. Circ. J. 56: 1081 1093.
204. Kuhl, U.,, M. Noutsias,, B. Seeberg,, M. Schannwell,, L. B. Welp,, H. P. Schultheiss,, and B. E. Strauer. 1994. Chronic inflammation in dilated cardiomyopathy. Heart Failure 9: 231 245.
205. Kyu, B.-S.,, A. Matsumori,, Y. Sato,, I. Okada,, N. M. Chapman,, and S. Tracy. 1992. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy. Circulation 86: 522 530.
206. Landau, B. J.,, P. S. Whittier,, S. D. Finkelstein,, B. Alstein,, J. B. Grun,, M. Schultz,, and R. L. Crowell. 1990. Induction of heterotypic virus resistance in adult inbred mice immunized with a variant of coxsackievirus B3. Microb. Pathog. 8: 289 298.
207. Lane, J. R.,, D. A. Neumann,, A. Lafond-Walker,, A. Herskowitz,, and N. R. Rose. 1992. Interleukin 1 or tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant BIO.A mice. J. Exp. Med. 175: 1123 1129.
208. Lane, J. R.,, D. A. Neumann,, A. Lafond-Walker,, A. Herskowitz,, and N. R. Rose. 1993. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J. Immunol. 151: 1682 1690.
209. Leist, T. P.,, S. P. Cobbold,, H. Waldmann,, M. Aguet,, and R. M. Zinkernagel. 1987. Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 138: 2278 2281.
210. Lerner, A. M. 1965. An experimental approach to virus myocarditis. Prog. Med. Virol. 7: 97 115.
211. Lerner, A. M.,, H. S. Levin,, and M. Finland. 1962. Age and susceptibility of mice to coxsackie A viruses. J. Exp. Med. 115: 745 762.
212. Lerner, A. M.,, and J. A. Shaka. 1962. Coxsackie A9 myocarditis in adult mice. Proc. Soc. Exp. Biol. Med. 111: 804 808.
213. Leslie, K.,, R. Blay,, C. Haisch,, A. Lodge,, A. Weller,, and S. Huber. 1989. Clinical and experimental aspects of viral myocarditis. Clin. Microbiol. Rev. 2: 191 203.
214. Leslie, K. O.,, J. Schwarz,, K. Simpson,, and S. A. Huber. 1990. Progressive interstitial collagen deposition in coxsackievirus B3-in-duced murine myocarditis. Am. J. Pathol. 136: 683 693.
215. Leung, D. Y. M.,, R. S. Geha,, J. W. Newburger,, J. C. Burns,, W. Fiers,, L. A. Lapierre,, and J. S. Pober. 1986. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J. Exp. Med. 164: 1958 1972.
216. Levander-Lindgren, M. 1965. Studies in myocarditis. IV. Late prognosis. Cardiologia 47: 209 220.
217. Levi, G.,, S. Scalvini,, M. Volterrani,, S. Marangoni,, G. Arosio,, and A. Quadri. 1988. Coxsackie virus heart disease; 15 years after. Eur. Heart J. 9: 1303 1307.
218. Lieberman, E. B.,, A. Herskowitz,, N. R. Rose,, and K. L. Baughman. 1993. A clinicopathologic description of myocarditis. Clin. Immunol. Immunopathol. 68: 191 196.
219. Lieberman, E. B.,, G. M. Hutchins,, A. Herskowitz,, N. R. Rose,, and K. L. Baughman. 1991. Clinicopathologic description of myocarditis. J. Am. Coll. Cardiol. 18: 1617 1626.
220. Liljas, L.,, A. M. Lindberg,, and U. Pettersson. 1993. Modelling of the tertiary structure of coxsackievirus B3 from the structure of poliovirus and rhinovirus. Scand. J. Infect. Dis. Suppl. 88: 15 24.
221. Liljeqvist, J.-A.,, T. Bergstrom,, S. Holmstrom,, A. Samuelson,, G. E. Yousef,, F. Waagstein,, and S. Jeansson. 1993. Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathy. J. Med. Virol. 39: 6 10.
222. Limas, C. J.,, I. F. Goldenberg,, and C. Limas. 1989. Autoantibodies against 0-adrenoceptors in human idiopathic dilated cardiomyopathy. Ore. Res. 64: 97 103.
223. Limas, C. J.,, I. F. Goldenberg,, and C. Limas. 1989. Effect of cardiac transplantation on anti-beta-receptor antibodies in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 63: 1134 1137.
224. Limas, C. J.,, I. F. Goldenberg,, and C. Limas. 1990. Influence of anti-beta-receptor antibodies on cardiac adenylate cyclase in patients with idiopathic dilated cardiomyopathy. Am. Heart J. 119: 1322 1328.
225. Limas, C. J.,, and C. Limas. 1991. Beta-adrenoceptor antibodies and genetics in dilated cardiomyopathy—an overview and review. Eur. Heart J. Suppl. D 12: 175 177.
226. Limas, C. J.,, and C. Limas. 1993. Immune-mediated modulation of β-adrenoceptor function in human dilated cardiomyopathy. Clin. Immunol. Immunopathol. 68: 204 207.
227. Limas, C. J.,, C. Limas,, and I. F. Goldenberg. 1991. Effect of antireceptor antibodies in dilated cardiomyopathy on cycling of cardiac beta receptors. Am. Heart J. 122: 108 114.
228. Limas, C. J.,, C. Limas,, S. H. Kubo,, and M. T. Olivari. 1990. Anti-beta-receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens. Am. f. Cardiol. 65: 483 487.
229. Lindberg, A. M.,, R. L. Crowell,, R. Zell,, R. Kandolf,, and U. Pettersson. 1992. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Res. 24: 187 196.
230. Lindberg, A. M.,, P. O. K. Stalhandske,, and U. Pettersson. 1987. Genome of coxsackievirus B3. Virology 156: 50 63.
231. Liu, P.,, P. R. McLaughlin,, and M. J. Sole. 1992. Treatment of myocarditis: current recommendations and future approaches. Heart Failure 8: 33 40.
232. Lodge, P. A.,, M. Herzum,, J. Olszewski,, and S. A. Huber. 1987. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. Am. J. Pathol. 128: 455 463.
233. Lonberg-Holm, K.,, R. L. Crowell,, and L. Philipson. 1976. Unrelated animal viruses share receptors. Nature (London) 259: 679 681.
234. Longson, M.,, F. Cole,, and D. Davies. 1969. Isolation of a coxsackie virus group B, type 5, from the heart of a fatal case of myocarditis in an adult. J. Clin. Pathol. 22: 654 658.
235. Loudon, R. P.,, A. F. Moraska,, S. A. Huber,, P. Schwimmbeck,, and P. Schultheiss. 1991. An attenuated variant of coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo. J. Virol. 65: 5813 5819.
236. Lowenstein, C. J.,, and S. H. Snyder. 1992. Nitric oxide, a novel biologic messenger. Cell 70: 705 707.
237. Lutton, C. W.,, and C. J. Gauntt. 1985. Ameliorating effect of IFN-β and anti-IFN-β on coxsackievirus B3-induced myocarditis in mice. J. Interferon Res. 5: 137 146.
238. Lutton, C. W.,, and C. J. Gauntt. 1986. Coxsackie B3 infection alters plasma membrane of neonatal skin fibroblasts. J. Virol. 60: 294 296.
239. Lutton, C. W.,, R. J. Gudvangen,, T. J. Nealon,, R. E. Paque,, and C. J. Gauntt. 1985. Cellular immune responses in mice challenged with an amyocarditic variant of coxsackievirus B3. J. Med. Virol. 17: 345 357.
240. Lyden, D.,, J. Olszewski,, and S. A. Huber. 1987. Influence of sex hormones on coxsackie virus group B, type 3 induced myocarditis in Balb/c mice. Eur. Heart J. Suppl. J 8: 389 391.
241. Lyden, D. C.,, and S. A. Huber. 1984. Aggravation of coxsackievirus, group B, type 3-induced myocarditis and increase in cellular immunity to myocyte antigens in pregnant Balb/c mice and animals treated with progesterone. Cell. Immunol. 87: 462 472.
242. MacArthur, C. G. C.,, D. Tarin,, J. F. Goodwin,, and K. A. Hallidie-Smith. 1984. The relationship of myocarditis to dilated cardiomyopathy. Eur. Heart J. 5: 1023 1035.
243. Magnusson, Y.,, S. Marullo,, S. Hoyer,, F. Waagstein,, B. Andersson,, A. Vahlne,, J. G. Guillet,, A. D. Strosberg,, A. Hjalmarson,, and J. Hoebeke. 1990. Mapping of a functional autoimmune epitope on the β,-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J. Clin. Invest. 86: 1658 1663.
244. Maisch, B.,, C. Hengstenberg,, C. Bethge,, M. Herzum,, G. Hufnagel,, and U. Schonian. 1994. Immunological factors in dilated cardiomyopathy. Heart Failure 9: 246 259.
245. Maisch, B.,, M. Herzum,, and U. Schonian. 1993. Immunomodulating factors and immunosuppressive drugs in the therapy of myocarditis. Scand.J. Infect. Dis. Suppl. 88: 149 162.
246. Maisch, B.,, R. Trostel-Soeder,, E. Stechemesser,, P. A. Berg,, and K. Kochsiek. 1982. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin. Exp. Immunol. 48: 533 545.
247. Mall, G.,, K. Klingel,, M. Albrecht,, M. Seemann,, P. Rieger,, and R. Kandolf. 1991. Natural history of coxsackievirus B3-induced myocarditis in ACA/Sn mice: viral persistence demonstrated by quantitative in situ hybridization histochemistry. Eur. Heart. J. Suppl. D 12: 121 123.
248. Mandin, J. M.,, and M. A. Mandin. 1963. Les pericarditis virales: considerations etiologiques a propos des virus coxsackie. Montpellier Med. 64: 20 22.
249. Mapoles, J. E.,, D. L. Krah,, and R. L. Crowell. 1985. Purification of a HeLa cell receptor protein for group B coxsackieviruses. J. Virol. 55: 560 566.
250. Marth, J. D.,, R. Peet,, E. G. Krebs,, and R. M. Perlmutter. 1985. A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA. Cell 43: 393 404.
251. Martino, T. A.,, P. Liu,, and M. J. Sole. 1994. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ. Res. 74: 182 188.
<